Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

Abstract The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. P. Arévalo, R. Pagotto, J. L. Pórfido, H. Daghero, M. Segovia, K. Yamasaki, B. Varela, M. Hill, J. M. Verdes, M. Duhalde Vega, M. Bollati-Fogolín, M. Crispo
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/164acd5bb54b4f4bbec1cff945980aed
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!